11 Recruiting Acute Myeloid Leukemia Phase 3 Clinical Trials
Active phase 3 studies for acute myeloid leukemia enrolling across the USA. Verify eligibility and contact site coordinators.
All Acute Myeloid Leukemia studiesPhase 3 Studies for Acute Myeloid Leukemia
🔵 Active, Not Recruiting Phase2 / Phase3
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
📍 O'Neal Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
📍 City of Hope National Medical Center /ID# 279568 — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase3
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
📍 Phoenix Children's Hospital — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
📍 US-San Francisco CA-UCSF — San Francisco, California
View Study & Checklist ➔